Jailyne Ojeda Of Leaked - Brightlocal News
Among subjects with eoe, there were no reports of conjunctivitis and keratitis in the dupixent group in placebo-controlled trials. In the 36-week active treatment extension period of study eoe-2 part b, … Learn more about dupixent® (dupilumab), the first fda-approved biologic to treat eosinophilic esophagitis (eoe) in adult and pediatric patients aged 1 year and older who weigh at least 33lb …
